$CLXT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Calyxt, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Calyxt, Inc.. Get notifications about new insider transactions in Calyxt, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | CLXT | Calyxt, Inc. | NEUGENT CHRISTOPHER J | Director | Buy | P | 3.95 | 15,000 | 59,291 | 15,000 | 0 to 15 K |
May 05 2021 | CLXT | Calyxt, Inc. | Ribeill Yves J | Executive Chair | Grant | A | 0.00 | 9,430 | 0 | 56,051 | 46.6 K to 56.1 K (+20.23 %) |
May 05 2021 | CLXT | Calyxt, Inc. | Ribeill Yves J | Executive Chair | Grant | A | 0.00 | 9,430 | 0 | 56,051 | 46.6 K to 56.1 K (+20.23 %) |
Apr 02 2021 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Grant | A | 0.00 | 16,591 | 0 | 46,621 | 30 K to 46.6 K (+55.25 %) |
Apr 02 2021 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Grant | A | 0.00 | 16,591 | 0 | 46,621 | 30 K to 46.6 K (+55.25 %) |
Mar 18 2021 | CLXT | Calyxt, Inc. | NEUGENT CHRISTOPHER J | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Mar 18 2021 | CLXT | Calyxt, Inc. | Koschak William | Chief Financial Off ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
Mar 18 2021 | CLXT | Calyxt, Inc. | Koschak William | Chief Financial Off ... | Option Exercise | A | 8.05 | 26,000 | 209,300 | 26,000 | |
Mar 18 2021 | CLXT | Calyxt, Inc. | Frimerman Debra H | General Counsel and ... | Option Exercise | A | 0.00 | 19,000 | 0 | 19,000 | |
Mar 18 2021 | CLXT | Calyxt, Inc. | Frimerman Debra H | General Counsel and ... | Option Exercise | A | 8.05 | 27,000 | 217,350 | 27,000 | |
Mar 18 2021 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Option Exercise | A | 0.00 | 16,500 | 0 | 16,500 | |
Mar 18 2021 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Option Exercise | A | 8.05 | 24,000 | 193,200 | 24,000 | |
Jan 05 2021 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 4.13 | 2,513 | 10,388 | 0 | 2.5 K to 0 (-100.00 %) |
Jan 04 2021 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 4.17 | 4,140 | 17,281 | 186,282 | 190.4 K to 186.3 K (-2.17 %) |
Dec 21 2020 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 4.75 | 5,026 | 23,874 | 2,513 | 7.5 K to 2.5 K (-66.67 %) |
Dec 02 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 3.79 | 150 | 569 | 2,900 | 2.8 K to 2.9 K (+5.45 %) |
Nov 04 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 3.26 | 150 | 489 | 2,750 | 2.6 K to 2.8 K (+5.77 %) |
Oct 02 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 5.47 | 150 | 820 | 2,600 | 2.5 K to 2.6 K (+6.12 %) |
Oct 01 2020 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 5.59 | 4,140 | 23,124 | 190,422 | 194.6 K to 190.4 K (-2.13 %) |
Sep 11 2020 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Buy | P | 5.91 | 3,000 | 17,729 | 6,290 | 3.3 K to 6.3 K (+91.19 %) |
Sep 01 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 5.41 | 150 | 811 | 2,450 | 2.3 K to 2.5 K (+6.52 %) |
Aug 21 2020 | CLXT | Calyxt, Inc. | Kozicz-Stankiewicz Anna Ewa | Director | Sell | S | 4.70 | 245 | 1,152 | 3,165 | 3.4 K to 3.2 K (-7.18 %) |
Aug 21 2020 | CLXT | Calyxt, Inc. | Kozicz-Stankiewicz Anna Ewa | Director | Sell | S | 2.87 | 245 | 703 | 3,410 | 3.7 K to 3.4 K (-6.70 %) |
Aug 21 2020 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Buy | P | 7.49 | 2,000 | 14,970 | 3,290 | 1.3 K to 3.3 K (+155.04 %) |
Aug 21 2020 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Sell | S | 4.70 | 236 | 1,109 | 1,290 | 1.5 K to 1.3 K (-15.47 %) |
Aug 21 2020 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Sell | S | 2.87 | 236 | 677 | 1,526 | 1.8 K to 1.5 K (-13.39 %) |
Aug 07 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Option Exercise | A | 4.55 | 25,000 | 113,750 | 25,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Frimerman Debra H | General Counsel | Option Exercise | A | 4.55 | 80,000 | 364,000 | 80,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Option Exercise | A | 4.55 | 80,000 | 364,000 | 80,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Option Exercise | A | 4.55 | 175,000 | 796,250 | 175,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Koschak William | Chief Financial Off ... | Option Exercise | A | 4.55 | 110,000 | 500,500 | 110,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Kozicz-Stankiewicz Anna Ewa | Director | Option Exercise | A | 4.55 | 5,000 | 22,750 | 5,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | A | 4.55 | 65,000 | 295,750 | 65,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Nelson Kimberly K. | Director | Option Exercise | A | 4.55 | 7,500 | 34,125 | 7,500 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | NEUGENT CHRISTOPHER J | Director | Option Exercise | A | 4.55 | 7,500 | 34,125 | 7,500 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Jonathan Fassberg | Director | Option Exercise | A | 4.55 | 5,000 | 22,750 | 5,000 | |
Aug 07 2020 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Option Exercise | A | 4.55 | 5,000 | 22,750 | 5,000 | |
Aug 03 2020 | CLXT | Calyxt, Inc. | Choulika Andre | Director | Sell | S | 4.65 | 4,228 | 19,647 | 130,815 | 135 K to 130.8 K (-3.13 %) |
Aug 03 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 4.36 | 150 | 654 | 2,300 | 2.2 K to 2.3 K (+6.98 %) |
Jul 31 2020 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 4.65 | 3,495 | 16,268 | 194,562 | 198.1 K to 194.6 K (-1.76 %) |
Jul 31 2020 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 5.01 | 2,902 | 14,532 | 198,057 | 201 K to 198.1 K (-1.44 %) |
Jul 01 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 5.04 | 156 | 786 | 2,150 | 2 K to 2.2 K (+7.82 %) |
Jun 02 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 4.43 | 144 | 638 | 1,994 | 1.9 K to 2 K (+7.78 %) |
May 04 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 4.32 | 175 | 755 | 1,850 | 1.7 K to 1.9 K (+10.45 %) |
Apr 02 2020 | CLXT | Calyxt, Inc. | Choulika Andre | Director | Payment of Exercise | F | 2.95 | 3,690 | 10,903 | 135,043 | 138.7 K to 135 K (-2.66 %) |
Apr 02 2020 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Payment of Exercise | F | 2.96 | 3,177 | 9,389 | 200,959 | 204.1 K to 201 K (-1.56 %) |
Apr 01 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 3.19 | 175 | 559 | 1,675 | 1.5 K to 1.7 K (+11.67 %) |
Mar 04 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 6.43 | 200 | 1,286 | 1,500 | 1.3 K to 1.5 K (+15.38 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.54 | 400 | 2,216 | 30,030 | 30.4 K to 30 K (-1.31 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.51 | 302 | 1,664 | 30,430 | 30.7 K to 30.4 K (-0.98 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.50 | 1,700 | 9,350 | 30,732 | 32.4 K to 30.7 K (-5.24 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.48 | 602 | 3,299 | 32,432 | 33 K to 32.4 K (-1.82 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.47 | 700 | 3,829 | 33,034 | 33.7 K to 33 K (-2.08 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.46 | 1,100 | 6,006 | 33,734 | 34.8 K to 33.7 K (-3.16 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.46 | 300 | 1,637 | 34,834 | 35.1 K to 34.8 K (-0.85 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.45 | 802 | 4,371 | 35,134 | 35.9 K to 35.1 K (-2.23 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.44 | 890 | 4,842 | 35,936 | 36.8 K to 35.9 K (-2.42 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.44 | 200 | 1,087 | 36,826 | 37 K to 36.8 K (-0.54 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.43 | 894 | 4,854 | 37,026 | 37.9 K to 37 K (-2.36 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.43 | 200 | 1,085 | 37,920 | 38.1 K to 37.9 K (-0.52 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.42 | 200 | 1,084 | 38,120 | 38.3 K to 38.1 K (-0.52 %) |
Mar 02 2020 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 5.41 | 1,700 | 9,197 | 38,320 | 40 K to 38.3 K (-4.25 %) |
Feb 04 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 5.61 | 200 | 1,122 | 1,300 | 1.1 K to 1.3 K (+18.18 %) |
Jan 17 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 7.89 | 275 | 2,170 | 1,100 | 825 to 1.1 K (+33.33 %) |
Jan 14 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology O ... | Buy | P | 7.24 | 275 | 1,990 | 825 | 550 to 825 (+50.00 %) |
Jan 14 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology O ... | Buy | P | 7.19 | 275 | 1,977 | 550 | 275 to 550 (+100.00 %) |
Jan 13 2020 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Buy | P | 7.64 | 275 | 2,101 | 275 | 0 to 275 |
Jan 07 2020 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Sell | S | 7.60 | 236 | 1,794 | 1,762 | 2 K to 1.8 K (-11.81 %) |
Jan 07 2020 | CLXT | Calyxt, Inc. | Kozicz-Stankiewicz Anna Ewa | Director | Sell | S | 7.65 | 245 | 1,874 | 3,655 | 3.9 K to 3.7 K (-6.28 %) |
Oct 03 2019 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Sell | S | 4.96 | 236 | 1,171 | 1,998 | 2.2 K to 2 K (-10.56 %) |
Oct 03 2019 | CLXT | Calyxt, Inc. | Kozicz-Stankiewicz Anna Ewa | Director | Sell | S | 4.96 | 245 | 1,215 | 3,900 | 4.1 K to 3.9 K (-5.91 %) |
Jul 22 2019 | CLXT | Calyxt, Inc. | Kozicz-Stankiewicz Anna Ewa | Director | Sell | S | 10.00 | 735 | 7,350 | 4,145 | 4.9 K to 4.1 K (-15.06 %) |
Jul 22 2019 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Sell | S | 10.00 | 706 | 7,060 | 2,234 | 2.9 K to 2.2 K (-24.01 %) |
Jul 02 2019 | CLXT | Calyxt, Inc. | Sahoo Manoj | Chief Commercial Of ... | Sell | S | 12.70 | 1,494 | 18,967 | 65,323 | 66.8 K to 65.3 K (-2.24 %) |
Jul 02 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Grant | A | 0.00 | 50,000 | 0 | 142,982 | 93 K to 143 K (+53.77 %) |
Jul 02 2019 | CLXT | Calyxt, Inc. | Frimerman Debra H | General Counsel | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jul 02 2019 | CLXT | Calyxt, Inc. | Koschak William | Chief Financial Off ... | Option Exercise | A | 0.00 | 85,000 | 0 | 85,000 | |
Jul 02 2019 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Option Exercise | A | 0.00 | 166,667 | 0 | 166,667 | |
Jul 02 2019 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Option Exercise | A | 12.48 | 125,000 | 1,560,000 | 125,000 | |
Jul 02 2019 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Grant | A | 0.00 | 50,000 | 0 | 204,136 | 154.1 K to 204.1 K (+32.44 %) |
Jun 18 2019 | CLXT | Calyxt, Inc. | Choulika Andre | Director | Payment of Exercise | F | 12.90 | 15,715 | 202,724 | 138,733 | 154.4 K to 138.7 K (-10.17 %) |
May 23 2019 | CLXT | Calyxt, Inc. | Frey Travis | Chief Technology Of ... | Option Exercise | A | 14.72 | 100,000 | 1,472,000 | 100,000 | |
May 17 2019 | CLXT | Calyxt, Inc. | Choulika Andre | Director | Option Exercise | A | 15.30 | 17,500 | 267,750 | 17,500 | |
May 15 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | A | 15.28 | 68,000 | 1,039,040 | 68,000 | |
May 15 2019 | CLXT | Calyxt, Inc. | Sahoo Manoj | Chief Commercial Of ... | Option Exercise | A | 15.28 | 68,000 | 1,039,040 | 68,000 | |
May 15 2019 | CLXT | Calyxt, Inc. | Frimerman Debra H | General Counsel | Option Exercise | A | 15.28 | 100,000 | 1,528,000 | 100,000 | |
May 15 2019 | CLXT | Calyxt, Inc. | Frimerman Debra H | General Counsel | Option Exercise | A | 15.28 | 100,000 | 1,528,000 | 100,000 | |
May 08 2019 | CLXT | Calyxt, Inc. | Choulika Andre | Director | Option Exercise | A | 15.59 | 7,500 | 116,925 | 7,500 | |
May 08 2019 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Option Exercise | A | 15.59 | 7,500 | 116,925 | 7,500 | |
May 08 2019 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Option Exercise | A | 15.59 | 7,500 | 116,925 | 7,500 | |
May 08 2019 | CLXT | Calyxt, Inc. | Jonathan Fassberg | Director | Option Exercise | A | 15.59 | 5,000 | 77,950 | 5,000 | |
May 08 2019 | CLXT | Calyxt, Inc. | NEUGENT CHRISTOPHER J | Director | Option Exercise | A | 15.59 | 5,000 | 77,950 | 5,000 | |
May 08 2019 | CLXT | Calyxt, Inc. | Kozicz-Stankiewicz Anna Ewa | Director | Option Exercise | A | 15.59 | 5,000 | 77,950 | 5,000 | |
May 08 2019 | CLXT | Calyxt, Inc. | Nelson Kimberly K. | Director | Option Exercise | A | 15.59 | 55,000 | 857,450 | 55,000 | |
Apr 30 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.59 | 3,750 | 13,463 | 204,611 | |
Apr 30 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 16.31 | 3,750 | 61,152 | 92,982 | 96.7 K to 93 K (-3.88 %) |
Apr 30 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.59 | 3,750 | 13,463 | 96,732 | 93 K to 96.7 K (+4.03 %) |
Apr 04 2019 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 16.65 | 2,582 | 42,982 | 154,136 | 156.7 K to 154.1 K (-1.65 %) |
Apr 02 2019 | CLXT | Calyxt, Inc. | Sahoo Manoj | Chief Commercial Of ... | Sell | S | 17.33 | 1,522 | 26,378 | 66,817 | 68.3 K to 66.8 K (-2.23 %) |
Mar 27 2019 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 17.87 | 2,582 | 46,129 | 156,718 | 159.3 K to 156.7 K (-1.62 %) |
Mar 21 2019 | CLXT | Calyxt, Inc. | Sahoo Manoj | Chief Commercial Of ... | Sell | S | 18.00 | 3,262 | 58,716 | 68,339 | 71.6 K to 68.3 K (-4.56 %) |
Mar 21 2019 | CLXT | Calyxt, Inc. | Sahoo Manoj | Chief Commercial Of ... | Sell | S | 18.00 | 5,068 | 91,224 | 71,601 | 76.7 K to 71.6 K (-6.61 %) |
Mar 20 2019 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 17.32 | 2,582 | 44,713 | 159,300 | 161.9 K to 159.3 K (-1.59 %) |
Mar 15 2019 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Sell | S | 16.58 | 2,582 | 42,802 | 161,882 | 164.5 K to 161.9 K (-1.57 %) |
Mar 15 2019 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 16.33 | 4,980 | 81,317 | 40,020 | 45 K to 40 K (-11.07 %) |
Mar 15 2019 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 16.08 | 5,000 | 80,410 | 45,000 | 50 K to 45 K (-10.00 %) |
Mar 15 2019 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 16.76 | 5,000 | 83,819 | 50,000 | 55 K to 50 K (-9.09 %) |
Mar 15 2019 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Sell | S | 17.39 | 5,000 | 86,958 | 55,000 | 60 K to 55 K (-8.33 %) |
Feb 26 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.59 | 3,977 | 14,277 | 208,361 | |
Feb 26 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 16.00 | 3,977 | 63,632 | 92,982 | 97 K to 93 K (-4.10 %) |
Feb 26 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.59 | 3,977 | 14,277 | 96,959 | 93 K to 97 K (+4.28 %) |
Feb 12 2019 | CLXT | Calyxt, Inc. | Koschak William | Chief Financial Off ... | Option Exercise | A | 13.01 | 180,000 | 2,341,800 | 180,000 | |
Feb 04 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.71 | 4,087 | 15,180 | 4,083 | |
Feb 04 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.71 | 4,083 | 15,165 | 8,170 | |
Feb 04 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 13.00 | 4,087 | 53,131 | 92,982 | 97.1 K to 93 K (-4.21 %) |
Feb 04 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.71 | 4,087 | 15,180 | 97,069 | 93 K to 97.1 K (+4.40 %) |
Feb 04 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 13.00 | 4,083 | 53,079 | 92,982 | 97.1 K to 93 K (-4.21 %) |
Feb 04 2019 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.71 | 4,083 | 15,165 | 97,065 | 93 K to 97.1 K (+4.39 %) |
Jan 08 2019 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Sell | S | 12.00 | 1,117 | 13,404 | 17,060 | 18.2 K to 17.1 K (-6.15 %) |
Dec 20 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.71 | 4,083 | 15,165 | 12,253 | |
Dec 20 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 13.00 | 4,083 | 53,079 | 92,982 | 97.1 K to 93 K (-4.21 %) |
Dec 20 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.71 | 4,083 | 15,165 | 97,065 | 93 K to 97.1 K (+4.39 %) |
Nov 13 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.71 | 4,083 | 15,165 | 16,336 | |
Nov 13 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 13.00 | 4,083 | 53,079 | 92,982 | 97.1 K to 93 K (-4.21 %) |
Nov 13 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.71 | 4,083 | 15,165 | 97,065 | 93 K to 97.1 K (+4.39 %) |
Oct 11 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.71 | 4,083 | 15,165 | 20,419 | |
Oct 11 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 13.84 | 4,083 | 56,514 | 92,982 | 97.1 K to 93 K (-4.21 %) |
Oct 11 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.71 | 4,083 | 15,165 | 97,065 | 93 K to 97.1 K (+4.39 %) |
Oct 10 2018 | CLXT | Calyxt, Inc. | NEUGENT CHRISTOPHER J | Director | Option Exercise | A | 14.24 | 29,400 | 418,656 | 29,400 | |
Oct 10 2018 | CLXT | Calyxt, Inc. | NEUGENT CHRISTOPHER J | Director | Grant | A | 0.00 | 19,600 | 0 | 19,600 | 0 to 19.6 K |
Oct 10 2018 | CLXT | Calyxt, Inc. | Jonathan Fassberg | Director | Option Exercise | A | 14.24 | 29,400 | 418,656 | 29,400 | |
Oct 10 2018 | CLXT | Calyxt, Inc. | Jonathan Fassberg | Director | Grant | A | 0.00 | 19,600 | 0 | 19,600 | 0 to 19.6 K |
Oct 10 2018 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Option Exercise | A | 17.10 | 180,000 | 3,078,000 | 180,000 | |
Oct 10 2018 | CLXT | Calyxt, Inc. | Ribeill Yves J | Director | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
Oct 10 2018 | CLXT | Calyxt, Inc. | Blome James | Chief Executive Off ... | Option Exercise | A | 14.24 | 200,000 | 2,848,000 | 200,000 | |
Oct 09 2018 | CLXT | Calyxt, Inc. | Dumont Philippe | Director | Sell | S | 14.11 | 1,117 | 15,765 | 18,177 | 19.3 K to 18.2 K (-5.79 %) |
Oct 03 2018 | CLXT | Calyxt, Inc. | Sahoo Manoj | Chief Commercial Of ... | Sell | S | 14.84 | 2,521 | 37,416 | 79,113 | 81.6 K to 79.1 K (-3.09 %) |
Sep 21 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.59 | 4,666 | 16,751 | 212,338 | |
Sep 21 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 16.00 | 4,666 | 74,656 | 92,982 | 97.6 K to 93 K (-4.78 %) |
Sep 21 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.59 | 4,666 | 16,751 | 97,648 | 93 K to 97.6 K (+5.02 %) |
Sep 11 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.71 | 4,083 | 15,165 | 24,502 | |
Sep 11 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 16.13 | 4,083 | 65,842 | 92,982 | 97.1 K to 93 K (-4.21 %) |
Sep 11 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.71 | 4,083 | 15,165 | 97,065 | 93 K to 97.1 K (+4.39 %) |
Aug 22 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.59 | 4,666 | 16,751 | 217,004 | |
Aug 22 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 17.31 | 4,666 | 80,768 | 92,982 | 97.6 K to 93 K (-4.78 %) |
Aug 22 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.59 | 4,666 | 16,751 | 97,648 | 93 K to 97.6 K (+5.02 %) |
Aug 10 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.71 | 4,083 | 15,165 | 28,585 | |
Aug 10 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Sell | S | 17.48 | 4,083 | 71,372 | 92,982 | 97.1 K to 93 K (-4.21 %) |
Aug 10 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Buy | M | 3.71 | 4,083 | 15,165 | 97,065 | 93 K to 97.1 K (+4.39 %) |
Jul 24 2018 | CLXT | Calyxt, Inc. | Voytas Daniel F | Chief Science Offic ... | Option Exercise | M | 3.59 | 4,666 | 16,751 | 221,670 |